Mainstream

Vanda Pharmaceuticals Targets $1b Revenue By 2030 With Expanded Psychiatry Portfolio

Vanda Pharmaceuticals targets $1B revenue by 2030 with expanded psychiatry portfolio

Vanda Pharmaceuticals targets $1B revenue by 2030 with expanded psychiatry portfolio

Post ContentvndaRead More

You might also be interested in reading Quest Diagnostics declares $0.80 dividend.

February 14, 2025
In Mainstream